Vulval dermatoses

References

• Wojnarowska F, Mayou R, Simkin S, Day A. Psychological characteristics and outcome of patients attending a clinic for vulval disease. J. Eur. Acad. Dermatol. Venereol.8, 121–129 (1997).
   Google Scholar
• Stewart EJC, Wojnarowska F, Marren PM. Experience in a clinic dedicated to the study of vulvar disorders. Br. J. Dermatol.133(Suppl. 45), 31–32 (1995).
   Google Scholar
• Fischer G, Spurrett B, Fischer A. The chronically symptomatic vulva: aetiology and management. Br. J. Obstet. Gynaecol.102(10), 773–779 (1995).
   PubMedGoogle Scholar
• Ridley C, Neill, SM. Non-infective cutaneous conditions of the vulva. In: The Vulva. Ridley CM, Neil SM (Eds). Blackwell Science Ltd, Oxford, UK121–186 (1999).
   Google Scholar
• Pincus SH. Vulvar dermatoses and pruritus vulvae. Dermatol. Clin.10(2), 297–308 (1992).
   PubMed Web of Science ®Google Scholar
• Crone AM, Stewart EJ, Wojnarowska F, Powell SM. Aetiological factors in vulvar dermatitis. J. Eur. Acad. Dermatol. Venereol.14(3), 181–186 (2000).
   PubMed Web of Science ®Google Scholar
• Marren P, Wojnarowska F. Dermatitis of the vulva. Semin. Dermatol.15(1), 36–41 (1996).
   PubMedGoogle Scholar
• Maibach HI, Mathias CT. Vulvar dermatitis and fissures – irritant dermatitis from methyl benzethonium chloride. Contact Dermatitis13(5), 340–41 (1985).
   PubMedGoogle Scholar
• Marren P, Wojnarowska F, Powell S. Allergic contact dermatitis and vulvar dermatoses. Br. J. Dermatol.126(1), 52–56 (1992).
   PubMed Web of Science ®Google Scholar
• Brenan JA, Dennerstein GJ, Sfameni SF, Drinkwater P, Marin G, Scurry JP. Evaluation of patch testing in patients with chronic vulvar symptoms. Australas. J. Dermatol.37(1), 40–43 (1996).
   PubMedGoogle Scholar
• Lewis FM, Shah M, Gawkrodger DJ. Contact sensitivity in pruritus vulvae: patch test results and clinical outcome. Am. J. Contact Dermatitis8(3), 137–140 (1997).
   PubMedGoogle Scholar
• Bircher AJ, Hirsbrunner P, Langauer S. Allergic contact dermatitis of the genitals from rubber additives in condoms. Contact Dermatitis28(2), 125–126 (1993).
   PubMedGoogle Scholar
• Presti ME, Druce HM. Hypersensitivity reactions to human seminal plasma. Ann. Allergy63(6 Pt 1), 477–481 (1989).
   PubMedGoogle Scholar
• Britz MB, Maibach HI. Human cutaneous vulvar reactivity to irritants. Contact Dermatitis5(6), 375–377 (1979).
   PubMed Web of Science ®Google Scholar
• Elsner P, Wilhelm D, Maibach HI. Sodium lauryl sulfate-induced irritant contact dermatitis in vulvar and forearm skin of premenopausal and postmenopausal women. J. Am. Acad. Dermatol.23(4 Pt 1), 648–652 (1990).
   PubMed Web of Science ®Google Scholar
• Elsner P, Wilhelm D, Maibach HI. Multiple parameter assessment of vulvar irritant contact dermatitis. Contact Dermatitis23(1), 20–26 (1990).
   PubMed Web of Science ®Google Scholar
• Margesson LJ. Vulvar disease pearls. Dermatol. Clin.24(2), 145–155 (2006).
   PubMed Web of Science ®Google Scholar
• Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study.Epidemiology of incontinence in the county of Nord-Trondelag. J. Clin. Epidemiol.53(11), 1150–1157 (2000).
   PubMed Web of Science ®Google Scholar
• Griffths CEM, Barker JNWN. Psoriasis. In: Rook’s Textbook of Dermatology. Burns T, Breathnach S, Cox NH, Griffiths CE (Eds). Blackwell Publishing, Oxford, UK 31–35, 69 (2005).
   Google Scholar
• Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients’ beliefs and attitudes towards the disease. Br. J. Dermatol.135(4), 533–537 (1996).
   PubMed Web of Science ®Google Scholar
• Andressen C, Henseler T. [Inheritance of psoriasis. Analysis of 2035 family histories]. Hautarzt33(4), 214–217 (1982).
   PubMed Web of Science ®Google Scholar
• Farber EM, Nall ML, Watson W. Natural history of psoriasis in 61 twin pairs. Arch. Dermatol.109(2), 207–211 (1974).
   PubMed Web of Science ®Google Scholar
• Capon F, Trembath RC, Barker JN. An update on the genetics of psoriasis. Dermatol. Clin.22(4), 339–347, vii (2004).
   PubMed Web of Science ®Google Scholar
• Barker JN. The pathophysiology of psoriasis. Lancet338(8761), 227–230 (1991).
   PubMed Web of Science ®Google Scholar
• Micheletti L, Preti M, Bogliatto F et al. Vulval lichen planus in the practice of a vulval clinic. Br. J. Dermatol.143(6),1349–1350 (2000).
   PubMedGoogle Scholar
• Margesson LJ. Contact dermatitis of the vulva. Dermatol. Ther.17(1), 20–27 (2004).
   PubMedGoogle Scholar
• Sander CS, Cooper SM, Ali I, Dean D, Thiele JJ, Wojnarowska F. Decreased antioxidant enzyme expression and increased oxidative damage in erosive lichen planus of the vulva. Br. J. Obstet. Gynaecol.112(11), 1572–1575 (2005).
   Google Scholar
• Cooper SM, Kirtschig G, Jeffery KJM, Wojnarowska F. No association between hepatitis B or C viruses and vulval lichen planus in a UK population. Br. J. Obstet. Gynaecol.111(3), 271–273 (2004).
   Google Scholar
• Tasker GL, Wojnarowska F. Lichen sclerosus. Clin. Exp. Dermatol.28(2), 128–133 (2003).
   PubMedGoogle Scholar
• Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J. Am. Acad. Dermatol.44, 803–806 (2001).
   PubMed Web of Science ®Google Scholar
• Wallace H. Lichen sclerosus et atrophicus. Trans. St John’s Hosp. Dermatol. Soc.57(1), 9–30 (1971).
   PubMedGoogle Scholar
• Meffert J, Davies BM, Grimwood RE. Lichen sclerosus. J. Am. Acad. Dermatol.32, 393–416 (1995).
   PubMed Web of Science ®Google Scholar
• Howard A, Dean D, Cooper S, Kirtshig G, Wojnarowska F. Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva. Australas. J. Dermatol.45(1), 12–15 (2004).
   PubMedGoogle Scholar
• Oyama N, Chan I, Neill SM et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet362(9378), 118–123 (2003).
   PubMed Web of Science ®Google Scholar
• Marren P, Yell J, Charnock FM et al. The association between lichen sclerosus and antigens of the HLA system. Br. J. Dermatol.132, 197–203 (1995).
   PubMed Web of Science ®Google Scholar
• Powell J, Wojnarowska F, Winsey S et al. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br. J. Dermatol.142, 481–484 (2000).
   PubMed Web of Science ®Google Scholar
• Gao X-H, Barnardo MCMN, Winsey S et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB1*12 and its associated DRB1*12//DQB1*0301//04//09//010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB1*0301//04 and its associated DRB1*0301//04//DQB1*0201//02//03 haplotype protects from vulval lichen sclerosus. J. Invest. Dermatol.125(5), 895–899 (2005).
   PubMed Web of Science ®Google Scholar
• Sander CS, Ali I, Dean D, Thiele JJ, Wojnarowska F. Oxidative stress is implicated in the pathogenesis of lichen sclerosus. Br. J. Dermatol.151(3), 627–635 (2004).
   PubMed Web of Science ®Google Scholar
• Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J. Am. Acad. Dermatol.33(4), 617–620 (1995).
   PubMed Web of Science ®Google Scholar
• Simpkin S, Oakley A. Clinical review of 202 patients with vulval lichen sclerosus: a possible association with psoriasis. Australas. J. Dermatol.48(1), 28–31 (2007).
   PubMedGoogle Scholar
• Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br. J. Dermatol.147(4), 640–649 (2002).
   PubMed Web of Science ®Google Scholar
• Hengge UR, Krause W, Hofmann H et al. Multicentre, Phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br. J. Dermatol.155(5), 1021–1028 (2006).
   PubMed Web of Science ®Google Scholar
• Cooper SM, Gao X-H, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch. Dermatol.140(6), 702–706 (2004).
   PubMedGoogle Scholar
• Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch. Dermatol.140(6), 709–712 (2004).
   PubMedGoogle Scholar
• Ansink AC, Krul MR, De Weger RA et al. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. Gynecol. Oncol.52(2), 180–184 (1994).
   PubMedGoogle Scholar
• Velazquez EF, Cubilla AL. Lichen sclerosus in 68 patients with squamous cell carcinoma of the penis: frequent atypias and correlation with special carcinoma variants suggests a precancerous role. Am. J. Surg. Pathol.27(11), 1448–1453 (2003).
   PubMed Web of Science ®Google Scholar
• von Krogh G, Dahlman-Ghozlan K, Syrjanen S. Potential human papillomavirus reactivation following topical corticosteroid therapy of genital lichen sclerosus and erosive lichen planus. J. Eur. Acad. Dermatol. Venereol.16(2), 130–133 (2002).
   PubMedGoogle Scholar
• Rosamilia LL, Schwartz JL, Lowe L et al. Vulvar melanoma in a 10-year-old girl in association with lichen sclerosus. J. Am. Acad. Dermatol.54(2 Suppl.), S52–S53 (2006).
   Google Scholar
• Marren P, Wojnarowska F, Venning V, Wilson C, Nayar M. Vulvar involvement in autoimmune bullous diseases. J. Reprod. Med.38(2), 101–107 (1993).
   PubMedGoogle Scholar
• Kirtschig G, Murrell D, Wojnarowska F, Khumalo N. Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database Syst. Rev.1, CD004056 (2003).
   Google Scholar
• Salim A, Wojnarowska F. Skin diseases affecting the vulva. Curr. Obstet. Gynaecol.12, 81–89 (2002).
   Google Scholar
• Sau M, Hill NC. Pyoderma gangrenosum of the vulva. Br. J. Obstet. Gynaecol.108(11), 1197–1198 (2001).
   Google Scholar